Minaprine
(Learn how and when to remove this message) Legal status |
---|
Legal status | - BR: Class C1 (Other controlled substances)[1]
- In general: ℞ (Prescription only)
|
---|
Pharmacokinetic data |
---|
Elimination half-life | 2-2.5 hours |
---|
Identifiers |
---|
|
CAS Number | - 25905-77-5 Y
|
---|
PubChem CID | |
---|
ChemSpider | - 4054 N
|
---|
UNII | |
---|
KEGG | - D05039 Y
|
---|
ChEMBL | - ChEMBL278819 N
|
---|
CompTox Dashboard (EPA) | - DTXSID5048477
|
---|
ECHA InfoCard | 100.043.012 |
---|
Chemical and physical data |
---|
Formula | C17H22N4O |
---|
Molar mass | 298.390 g·mol−1 |
---|
3D model (JSmol) | |
---|
|
NY (what is this?) (verify) |
Minaprine (INN, USAN, BAN; brand names Brantur, Cantor) is a monoamine oxidase inhibitor antidepressant drug[2] that was used in France for the treatment of depression until it was withdrawn from the market in 1996 because it caused convulsions.[3]
A study found that it acts as a reversible inhibitor of MAO-A (RIMA) in rats.[4] It has also been found to weakly inhibit acetylcholinesterase in rat brain (striatum) homogenates.[5]
It has demonstrated significant antibiotic activity against M. chelonae and M. abscessus in tests with antibiotic resistant bacteria.[6]
Minaprine is a member of pyridazines, a secondary amine and a member of morpholines. It has a role as an antidepressant, a serotonin uptake inhibitor, a dopamine uptake inhibitor, a cholinergic drug and an antiparkinson drug.[7]
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ "Minaprine - an overview | ScienceDirect Topics". www.sciencedirect.com. Retrieved 2023-12-14.
- ^ Fung M, Thornton A, Mybeck K, Wu JH, Hornbuckle K, Muniz E (1 January 2001). "Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999". Therapeutic Innovation & Regulatory Science. 35 (1): 293–317. doi:10.1177/009286150103500134. S2CID 73036562.
- ^ Kan JP, Mouget-Goniot C, Worms P, Biziere K (March 1986). "Effect of the antidepressant minaprine on both forms of monoamine oxidase in the rat". Biochemical Pharmacology. 35 (6): 973–978. doi:10.1016/0006-2952(86)90085-7. PMID 3954800.
- ^ Contreras JM, Rival YM, Chayer S, Bourguignon JJ, Wermuth CG (February 1999). "Aminopyridazines as acetylcholinesterase inhibitors". Journal of Medicinal Chemistry. 42 (4): 730–741. doi:10.1021/jm981101z. PMID 10052979.
- ^ Chopra S, Matsuyama K, Hutson C, Madrid P (July 2011). "Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae". The Journal of Antimicrobial Chemotherapy. 66 (7): 1533–1536. doi:10.1093/jac/dkr154. PMID 21486854.
- ^ PubChem. "Minaprine". pubchem.ncbi.nlm.nih.gov. Retrieved 2023-12-14.
|
---|
SSRIsTooltip Selective serotonin reuptake inhibitors | |
---|
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors | |
---|
NRIsTooltip Norepinephrine reuptake inhibitors | |
---|
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors | |
---|
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants | |
---|
SARIsTooltip Serotonin antagonist and reuptake inhibitors | |
---|
SMSTooltip Serotonin modulator and stimulators | |
---|
Others | |
---|
|
|
|
---|
TCAsTooltip Tricyclic antidepressants | |
---|
TeCAsTooltip Tetracyclic antidepressants | |
---|
Others | |
---|
|
|
|
---|
Non-selective | |
---|
MAOATooltip Monoamine oxidase A-selective | |
---|
MAOBTooltip Monoamine oxidase B-selective | |
---|
|
|
|
|
|
|
---|
Enzyme (modulators) | ChATTooltip Choline acetyltransferase | - Inhibitors: 1-(-Benzoylethyl)pyridinium
- 2-(α-Naphthoyl)ethyltrimethylammonium
- 3-Chloro-4-stillbazole
- 4-(1-Naphthylvinyl)pyridine
- Acetylseco hemicholinium-3
- Acryloylcholine
- AF64A
- B115
- BETA
- CM-54,903
- N,N-Dimethylaminoethylacrylate
- N,N-Dimethylaminoethylchloroacetate
|
---|
AChETooltip Acetylcholinesterase | |
---|
BChETooltip Butyrylcholinesterase | |
---|
|
---|
Transporter (modulators) | CHTTooltip Choline transporter | |
---|
VAChTTooltip Vesicular acetylcholine transporter | |
---|
|
---|
Release (modulators) | |
---|
- See also
- Receptor/signaling modulators
- Muscarinic acetylcholine receptor modulators
- Nicotinic acetylcholine receptor modulators
|
|
---|
Non-specific | AAADTooltip Aromatic L-amino acid decarboxylase | |
---|
MAOTooltip Monoamine oxidase | |
---|
|
---|
Phenethylamines (dopamine, epinephrine, norepinephrine) | PAHTooltip Phenylalanine hydroxylase | |
---|
THTooltip Tyrosine hydroxylase | - Substrates→Products: Tyrosine→L-DOPA (levodopa)
|
---|
DBHTooltip Dopamine beta-monooxygenase | |
---|
PNMTTooltip Phenylethanolamine N-methyltransferase | - Inhibitors: CGS-19281A
- SKF-64139
- SKF-7698
|
---|
COMTTooltip Catechol-O-methyl transferase | |
---|
|
---|
Tryptamines (serotonin, melatonin) | TPHTooltip Tryptophan hydroxylase | |
---|
AANATTooltip Serotonin N-acetyl transferase | |
---|
ASMTTooltip Acetylserotonin O-methyltransferase | |
---|
|
---|
Histamine | HDCTooltip Histidine decarboxylase | |
---|
HNMTTooltip Histamine N-methyltransferase | - Substrates→Products: Histamine→N-Methylhistamine
|
---|
DAOTooltip Diamine oxidase | - Substrates→Products: Histamine→Imidazole acetic acid
|
---|
|
---|
See also: Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins |
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |